 |
 |
 |
 |
 |
|
|
| Article 1 to 2 out of 2 concerning Xenon Pharmaceuticals Inc.
|
-
Xenon Enters Into Anemia Collaboration With Roche
(12/12/2006)
Xenon to Receive $7 Million for Equity, and Could Potentially Receive $44 Million From Research Funding and Milestone Payments
Xenon announced a partnership with Roche to discover and develop protein therapeutics targeting hemojuvelin (HJV) as a novel approach for the treatment of anemia of inflammation. Xenon discovered HJV as the defective protein underlying Juvenile ...
-
Xenon Genetics Inc. Changes Name to Xenon Pharmaceuticals Inc.
(06/30/2004)
Vancouver. Xenon Genetics Inc. announced that, effective immediately, it has changed its name to Xenon Pharmaceuticals Inc. The new name more accurately reflects Xenon's drug discovery and development focus and the Company's goal of commercializing ...
 |
|
|
|
|